topics


Drug Safety

Pew Leadership: Senate Committee Testimony
Issue Brief

Pew Leadership: Senate Committee Testimony

FDA User Fee legislation
image description

Drug Safety News & Resources

Pew Testimony Before the U.S.-China Economic and Security Review Commission

Other Resource Apr 3, 2014 Drug Safety Project

Allan Coukell, senior director of drugs and medical devices, testified before the U.S.-China Economic and Security Review Commission on the global pharmaceutical supply chain security and the importance of the newly passed Drug Quality and Security Act.

More

Testimony of Elizabeth Jungman on Counterfeit Medicines

Issue Brief Feb 27, 2014 Drug Safety Project

The House Energy and Commerce Subcommittee on Oversight and Investigation held a hearing on Feb 16 entitled "Counterfeit Drugs: Fighting Illegal Supply Chains." Elizabeth Jungman, director of drug safety and innovation testified on counterfeit drugs the importance that newly passed Drug Quality and Security Act will have on the safety of the U.S. pharmaceutical supply chain.

 

More

Case Studies: How Unsafe Drugs Can Reach Patients

Issue Brief Feb 26, 2014 Drug Safety Project

The following case studies illustrate breaches to the pharmaceutical supply chain—the route a drug travels from its raw material origins to the delivery of a finished medicine. These examples, all of which are discussed in Pew Health Group’s report After Heparin: Protecting Consumers from the Risks of Substandard and Counterfeit Drugs, demonstrate the different ways in which contaminated, fake, or otherwise unsafe medicine can reach patients, and underscore the need for reform.

More

Pew Comments to FDA Draft Guidance on 503A

Issue Brief Feb 3, 2014 Drug Safety Project

On January 31, Pew submitted comments to the U.S. Food and Drug Administration in response to draft guidance on the implementation of Title I of the Drug Quality and Security Act and addressed five topics: anticipatory and office stock compounding; quality standards; FDA / state coordination; MOUs to address inordinate interstate shipment of compounded drugs; use of bulk drug substances.

More

Improving the Safety and Quality of Our Drug Supply

Other Resource Nov 27, 2013 Drug Safety Project
On Nov. 18, 2013, Congress passed the landmark Drug Quality and Security Act, bipartisan legislation to safeguard the U.S. pharmaceutical supply from counterfeit and contaminated drugs. The act creates a national system to track and authenticate prescription medications as they progress from the manufacturer to the patient. It also addresses the risks posed by drugs made by large-scale compounding pharmacies. More

Pew Hails Passage of Drug Quality and Security Act, a Step Forward for Drug and Patient Safety

Press Release Nov 18, 2013 Drug Safety Project

In response to final Senate passage of the Drug Quality and Security Act—legislation that establishes a national standard for tracing pharmaceuticals through the drug supply system and clarifies federal authority over pharmaceutical compounding—Allan Coukell, senior director of drugs and medical devices at The Pew Charitable Trusts, issued the following statement.

More

Associated Press: Pharmacy Bill Set for Test Vote in Senate

Media Coverage Nov 12, 2013 Drug Safety Project

A year after a meningitis outbreak from contaminated pain injections killed at least 64 people and sickened hundreds, Congress is ready to increase federal oversight over compounding pharmacies that custom-mix medications.

More

Minneapolis Star-Tribune: U.S. Senate Must Act on Pharmacy Safeguards

Opinion Nov 8, 2013 Drug Safety Project

It's been more than a year since a deadly fungal meningitis outbreak traced to a filthy New England compounding pharmacy put a shocking spotlight on the risks of medications mass-produced by underregulated firms.

More

Letter from Pew and The Pharmaceutical Distribution Security Alliance to Senate Leadership Calling for Passage of Track and Trace Legislation

Other Resource Oct 24, 2013 Drug Safety Project

Pew and the Pharmaceutical Distribution Security Alliance, or PDSA, PDSA have co-signed a letter asking Majority Leader Harry Reid (D-NV) and Republican Leader Mitch McConnell (R-KY) to pass The Drug Quality and Security Act (HR 3204), which would implement a “track and trace” system for the U.S. pharmaceutical distribution supply chain and enhanced federal oversight of compounding pharmacies to safeguard the nation’s drug supply against counterfeit and contaminated medicines.

More

NBC News: A Year Later, Fungal Meningitis Victims Still Suffering, but Rebuilding

Media Coverage Oct 22, 2013 Drug Safety Project

A year after a deadly fungal meningitis outbreak tied to tainted pain shots, victims like Margaret Snopkowski say they remain devastated by the ordeal — but determined to rebuild their lives.

More

See More
AIP_Hospital_flip1280x840_km_RF